All these data show that CTLA4 inhibited plaque development by generating anti-inflammatory T cell responses, whereas CD80/86-CD28 co-stimulation promoted atherosclerosis by eliciting Th1 responses. The gene discussed is CD28; the disease is atherosclerosis.